Details for New Drug Application (NDA): 019660
✉ Email this page to a colleague
The generic ingredient in TILADE is nedocromil sodium. There are three drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the nedocromil sodium profile page.
Summary for 019660
Tradename: | TILADE |
Applicant: | King Pharms Llc |
Ingredient: | nedocromil sodium |
Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 019660
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | AEROSOL, METERED;INHALATION | Strength | 1.75MG/INH | ||||
Approval Date: | Dec 30, 1992 | TE: | RLD: | No |
Expired US Patents for NDA 019660
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
King Pharms Llc | TILADE | nedocromil sodium | AEROSOL, METERED;INHALATION | 019660-001 | Dec 30, 1992 | ⤷ Sign Up | ⤷ Sign Up |
King Pharms Llc | TILADE | nedocromil sodium | AEROSOL, METERED;INHALATION | 019660-001 | Dec 30, 1992 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription